Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca plans $150m plant in Russia

February 22, 2011
Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing

AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …

News

Quality problems lead to short-term layoffs at Baxter Ireland

February 22, 2011
Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis

A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …

News
oxford_biomedica__manufacturing_james_christie

James Christie joins Oxford BioMedica as manufacturing head

February 22, 2011
Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production

UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …

Appointment

SHL to speak at Drug Delivery System Development and Lifecycle Management Requirements for Biologic Pharmaceuticals: Trends and Best Practices

February 22, 2011
Manufacturing and Production auto injector, autoinjector, drug delivery, shl group

The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations …

News
Press release
Counterfeit Plavix

Europe votes in new anti-counterfeit law

February 21, 2011
Manufacturing and Production EFPIA, counterfeits, supply chain

The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …

News

Four steps to turn around a flagging pharma brand

February 21, 2011
Sales and Marketing MSI, branding, brands, marketing

The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …

Feature
idea_michael_morgan-curran

Idea Pharma boosts UK and US teams

February 21, 2011
Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing

Idea Pharma has made new appointments to its UK- and US-based teams

Appointment

Astellas to commercialise new kidney cancer drug in Europe

February 21, 2011
Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib

Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …

News

J&J hit by another string of product recalls

February 21, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls

There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …

News
Merck KGaA

Merck KGaA sales soar

February 21, 2011
Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro

Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …

News

Matt de Gruchy to lead Ogilvy Healthworld UK

February 18, 2011
Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications

Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …

Appointment
Blog footer

Digital Pharma: Merck Serono sets up MS social network

February 18, 2011
Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking

Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …

News
Merck Serono headquarters

Merck Serono halts Movectro European licence application

February 18, 2011
Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis

Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …

News

Value-based pricing will not harm industry, says NICE chief

February 18, 2011
Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing

NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …

News

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011
Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …

News

Trial failures threaten UK biotech

February 18, 2011
Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech

A number of late stage failures from British biotech firms have left a looming question mark over the future of …

News

Bennett appointed chairman of Monitor

February 18, 2011
Sales and Marketing Monitor, NHS

Monitor, the body which will take on a powerful new role in regulating competition in the NHS, has a new …

News

Vidaza patient access scheme sways NICE

February 17, 2011
Sales and Marketing Celgene, NICE, Vidaza

Celgene’s Vidaza has been recommended by NICE in final draft guidance issued today. Vidaza (azacitidine) is recommended as a treatment …

News

e-Therapeutics success in £17 million financing

February 17, 2011
Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics

UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …

News
Tyverb

Pharma industry R&D pipelines

February 16, 2011
Research and Development pipeline, pipelines

 New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026